 The use of the sorption material vitaevalis was found to be highly effective in treating purulent inflammatory processes of the maxillofacial area. It reduced the duration of hospital stay by 4.35 plus or minus 1.41 days compared to the control group. Additionally, the sorbent promoted faster recovery of the patient's condition and improved the quality of life. This article was authored by D.I. Tazin, M.N. Chakarov, I.D. Tazin, and others.